Food factory fires 2022 not just the US

UK

Crews tackle 'ferocious' fire at Harlow sausage factory

https://www.bbc.com/news/uk-england-essex-61227225

Netherlands

Duizenden kippen overleden bij uitslaande brand in stal in Heusden

https://www.ad.nl/binnenland/duizenden-kippen-overleden-bij-uitslaande-brand-in-stal-in-heusden~a61befaf/?referrer=https%3A%2F%2Fbeforeitsnews.com%2F

Australia

Adelaide business gutted by fire nothing left of Vita Foods, which imports goods from India and supplies retailers around the country.

https://www.9news.com.au/national/vita-foods-warehouse-fire-long-road-recovery-adelaide-business/2ad188e1-a962-491b-ae45-79dc8a751343

Massive fire engulfs Brunswick East business in Melbourne's inner north

https://www.abc.net.au/news/2022-04-07/large-factory-fire-in-brunswick-east/100973980

Chemical fire engulfs Moorebank food factory in southwest Sydney

https://www.facebook.com/7NewsAustralia/videos/chemical-fire-engulfs-moorebank-food-factory-in-southwest-sydney/955234548152059/

Canada

5 people injured in explosion, fire at Sherbrooke food-processing hub

https://www.cbc.ca/news/canada/montreal/sherbrooke-food-lab-fire-1.6394381

Multiple alarm fire at food processing operation on Hamilton Mountain

https://globalnews.ca/news/8495136/fire-industrial-building-hamilton-mountain/

Bangladesh

Thursday night at the five-storey Hashem Foods Ltd. factory in Rupganj, just outside Dhaka, sending huge clouds of black smoke billowing into the sky.

https://www.ctvnews.ca/world/52-dead-in-bangladesh-factory-fire-as-workers-locked-inside-1.5502733

Family Launches Billboard Campaign – Claims Pfizer Drugs and Wisconsin Hospital Killed Their Daughter Grace

On October 13, 2021, Grace Schara passed away at Ascension’s St. Elizabeth’s Hospital in Wisconsin. Her parents say the doctors and hospital killed Grace by their insistence to follow ineffective COVID treatment protocols.

UncoverDC reported on this tragic story.

On Oct. 13, 2021, at 7:27 pm, beautiful Grace Schara—an inquisitive young woman with Down-Syndrome—died a tragic and preventable death at a Wisconsin hospital. Rather than using treatments proven to combat COVID-19, Ascension’s St. Elizabeth’s Hospital followed the U.S. government’s ineffective COVID-19 treatment protocols, for which they reap significant financial rewards. On the final day of Grace’s life, as her doctor assured her parents she was doing well, Dr. Gavin Shokar also “unilaterally labeled Grace a DNR and ordered a lethal combination of IV sedatives and narcotics”—a fatal combination of the drugs Precedex, Lorazepam, and Morphine—which were administered over an incredibly short period of time. Notably, all three drugs are manufactured by mRNA “vaccine” maker and pharmaceutical giant Pfizer.

The Schara family is still speaking out about their daughter’s tragic death.

The family of Grace Shara is now running over a dozen billboards in the FOX Valley area.

From the press release:

Grace was admitted to St. Elizabeth’s for Covid-19 respiratory issues, but was recovering before a doctor began giving sedatives to her.

Dr. Gavin Shokar, MD, apparently found it so likely she would die from his administration of Precedex – a powerful sedative used in surgery – that he wrote his own do-not-resuscitate (DNR) order on her a mere eight minutes after giving her the maximum dose. When Grace was still alive Shokar then combined Precedex with Lorazepam (another powerful sedative) and a Morphine push within minutes of one another on Grace’s last day to finish her off. A 14-year ICU nurse, Hollee McInnis, delivered the lethal dosage.

“Each of these medicines, on their own, have an increased risk of serious or life-threatening breathing problems and cardiac arrest,” said a doctor familiar with Grace’s case. “There’s an additive effect when used in combination. To use them like they did in a person with a diagnosis of acute respiratory distress is beyond believable as to intention,” she said.

A DNR order is legally required to be discussed with family and consented to in writing, neither of which occurred in Grace’s case. Grace was not given a DNR bracelet, which is required by law. In fact, family members were never told Grace had a DNR designation until her last breaths, when doctors and nurses did nothing to help her, despite the family telling them Grace didn’t have a DNR. Apathetic medical staff allowed Grace to die as her sister at her bedside helplessly begged them to revive her, while her parents – who were not allowed in her room – watched her die via FaceTime.

https://www.thegatewaypundit.com/2022/04/family-launches-billboard-campaign-claims-pfizer-drugs-wisconsin-hospital-killed-daughter-grace/

Alphabet Plummets 7% After Missing On Earnings, YouTube Revenues, Despite New $70BN Stock Buyback

Heading into today's post-market earnings juggernaut, which includes GOOGL, MSFT, V, GM, TXN and others, the two companies investors were most focused on were Microsoft and Google, pardon Alphabet, the second and third largest US companies by market cap, and which had been monkeyhammered heading into today's close amid fears of another catastrophic report. As in prior quarters, investors will be laser focused on progress in Alphabet’s Google Cloud segment. The internet company’s cloud-computing unit is the No. 3 player in the U.S., behind Amazon Web Services and Microsoft’s Azure. Investors will also want to know how YouTube is performing.

But the far bigger question is whether Alphabet would continue the trend of earnings misses set last week with Netflix and ahead of the coming earnings from Amazon, Microsoft and Facebook.

The answer, at least judging by the stock's kneejerk reaction which is sharply lower, was a solid no. Here are the results:

EPS $24.62 vs. $26.29 y/y, missing estimates of $25.71

Revenue $68.01 billion, +23% y/y, beating the estimate of $67.98 billion

Revenue ex-TAC $56.02 billion, +23% y/y, missing the estimate of $56.077 billion

Google advertising revenue $54.66 billion, +22% Y/Y, beating estimates of $54.13 billion

Google other revenue $6.81 billion, +4.9% Y/Y, missing estimates of $7.28 billion

Google Services revenue $61.47 billion, +20% Y/Y, missing estimates of $62.58 billion

Google Cloud revenue $5.82 billion, +44% Y/Y, beating estimates of $5.77 billion

Other Bets revenue $440 million, beating estimates of $203.9 million

Operating income $20.09 billion, +22% y/y, beating estimates of $19.7 billion

Google Services operating income $22.92 billion, +17% y/y, beating estimates of $22.15 billion

Google Cloud operating loss $931 million, -4.4% y/y, missing the estimate loss $893.2 million

Other Bets operating loss $1.16 billion, +0.9% y/y

Operating margin 30% vs. 30% y/y, estimate 28.8%

Capital expenditure $9.79 billion, estimate $7.28 billion

Number of employees 163,906, +17% y/y, estimate 161,312

The company also announced plans to buy back up to an additional $70.0BN Class A & Class C Shares.

https://www.zerohedge.com/markets/alphabet-plummets-7-after-missing-earnings-youtube-revenues-despite-new-70bn-stock-buyback

>>16159275

The Limits to Growth

https://www.clubofrome.org/publication/the-limits-to-growth/

Pfizer asks FDA to authorize third COVID vax dose for children 5 to 11 years old

NEW YORK and MAINZ, GERMANY, APRIL 26, 2022 (Pfizer / NEWS RELEASE)— Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of a 10-µg booster dose of the Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age (also referred to as children ages 5 through <12).

The submission included data from the Phase 2/3 clinical trial in children ages 5 through 11 years who received a booster dose approximately 6 months after the second dose of the Pfizer-BioNTech COVID-19 Vaccine 10-µg two-dose primary series, which was authorized under EUA for this age group in October 2021. Data from this study demonstrated a strong immune response in this age group following a booster dose of the Pfizer-BioNTech COVID-19 Vaccine with no new safety signals.

The companies also plan to submit these data to the European Medicines Agency (EMA) and other regulatory agencies around the world for authorization in the coming weeks.

The Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech’s proprietary mRNA technology, was developed by both BioNTech and Pfizer. BioNTech is the Marketing Authorization Holder in the United States, the European Union, the United Kingdom, Canada and the holder of emergency use authorizations or equivalents in the United States (jointly with Pfizer) and other countries. Submissions to pursue regulatory approvals in those countries where emergency use authorizations or equivalent were initially granted are planned.

About the Phase 1/2/3 Trial in Children

The Phase 1/2/3 trial initially enrolled up to 4,500 children ages 6 months to under 12 years of age in the United States, Finland, Poland, and Spain from more than 90 clinical trial sites. Additional children have been enrolled in all age groups following study amendments and the trial currently includes more than 10,000 children. The trial was originally designed to evaluate the safety, tolerability, and immunogenicity of the Pfizer-BioNTech COVID-19 Vaccine on a two-dose schedule (approximately 21 days apart) in three age groups: ages 5 to under 12 years; ages 2 to under 5 years; and ages 6 months to under 2 years. Based on the Phase 1 dose-escalation portion of the trial, children ages 5 to under 12 years received a two-dose schedule of 10-µg each while children under age 5 received a lower 3-µg dose for each injection in the Phase 2/3 study. The trial enrolled children with or without prior evidence of SARS-CoV-2 infection. In December 2021, Pfizer and BioNTech announced the companies would test a third 3-µg dose given at least two months after the second dose in children under age 5 and a third dose of the 10-µg formulation in children 5 to under 12 years of age. The companies expect to share data from the ongoing study in children 6 months to under 5 years of age later this quarter.

https://breaking911.com/breaking-pfizer-asks-fda-to-authorize-third-covid-vax-dose-for-children-5-to-11-years-old/

Pfizer asks FDA to authorize third COVID vax dose for children 5 to 11 years old

NEW YORK and MAINZ, GERMANY, APRIL 26, 2022 (Pfizer / NEWS RELEASE)— Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of a 10-µg booster dose of the Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age (also referred to as children ages 5 through <12).

The submission included data from the Phase 2/3 clinical trial in children ages 5 through 11 years who received a booster dose approximately 6 months after the second dose of the Pfizer-BioNTech COVID-19 Vaccine 10-µg two-dose primary series, which was authorized under EUA for this age group in October 2021. Data from this study demonstrated a strong immune response in this age group following a booster dose of the Pfizer-BioNTech COVID-19 Vaccine with no new safety signals.

The companies also plan to submit these data to the European Medicines Agency (EMA) and other regulatory agencies around the world for authorization in the coming weeks.

The Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech’s proprietary mRNA technology, was developed by both BioNTech and Pfizer. BioNTech is the Marketing Authorization Holder in the United States, the European Union, the United Kingdom, Canada and the holder of emergency use authorizations or equivalents in the United States (jointly with Pfizer) and other countries. Submissions to pursue regulatory approvals in those countries where emergency use authorizations or equivalent were initially granted are planned.

About the Phase 1/2/3 Trial in Children

The Phase 1/2/3 trial initially enrolled up to 4,500 children ages 6 months to under 12 years of age in the United States, Finland, Poland, and Spain from more than 90 clinical trial sites. Additional children have been enrolled in all age groups following study amendments and the trial currently includes more than 10,000 children. The trial was originally designed to evaluate the safety, tolerability, and immunogenicity of the Pfizer-BioNTech COVID-19 Vaccine on a two-dose schedule (approximately 21 days apart) in three age groups: ages 5 to under 12 years; ages 2 to under 5 years; and ages 6 months to under 2 years. Based on the Phase 1 dose-escalation portion of the trial, children ages 5 to under 12 years received a two-dose schedule of 10-µg each while children under age 5 received a lower 3-µg dose for each injection in the Phase 2/3 study. The trial enrolled children with or without prior evidence of SARS-CoV-2 infection. In December 2021, Pfizer and BioNTech announced the companies would test a third 3-µg dose given at least two months after the second dose in children under age 5 and a third dose of the 10-µg formulation in children 5 to under 12 years of age. The companies expect to share data from the ongoing study in children 6 months to under 5 years of age later this quarter.

https://breaking911.com/breaking-pfizer-asks-fda-to-authorize-third-covid-vax-dose-for-children-5-to-11-years-old/

Biden Uses Sweeping Clemency Powers For The First Time | FULL LIST

Today, President Joe Biden granted clemency to 78 individuals, consisting of three pardons of felons and 75 commutations.

Full list as provided by the Justice Department:

Abraham W. Bolden, Sr. – Chicago, Illinois Abraham Bolden is an 86-year-old former U.S. Secret Service agent and was the first African American to serve on a presidential detail. In 1964, Mr. Bolden was charged with offenses related to attempting to sell a copy of a Secret Service file. His first trial resulted in a hung jury, and following his conviction at a second trial, even though key witnesses against him admitted to lying at the prosecutor’s request, Mr. Bolden was denied a new trial and ultimately served several years in federal custody. He has steadfastly maintained his innocence, arguing that he was targeted for prosecution in retaliation for exposing unprofessional and racist behavior within the U.S. Secret Service. Mr. Bolden has received numerous honors and awards for his ongoing work to speak out against the racism he faced in the Secret Service in the 1960s, and his courage in challenging injustice. Mr. Bolden has also been recognized for his many contributions to his community following his release from prison.

Betty Jo Bogans – Houston, Texas Betty Jo Bogans is a 51-year-old woman who was convicted in 1998 of possession with intent to distribute crack cocaine in the Southern District of Texas after attempting to transport drugs for her boyfriend and his accomplice, neither of whom were detained or arrested. At the time of her conviction, Ms. Bogans was a single mother with no prior record, who accepted responsibility for her limited role in the offense. Because of the harsh penalties in place at the time she was convicted, Ms. Bogan received a seven-year sentence. In the nearly two decades since her release from custody, Ms. Bogans has held consistent employment, even while undergoing treatment for cancer, and has focused on raising her son.

Dexter Eugene Jackson – Athens, Georgia Dexter Jackson is a 52-year-old man who was convicted in 2002 for using his business to facilitate the distribution of marijuana in the Northern District of Georgia. Mr. Jackson was not personally involved in trafficking marijuana, but allowed marijuana distributors to use his pool hall to facilitate drug transactions. He accepted full responsibility for his actions at the time he was charged, and pled guilty. Since his release from custody, Mr. Jackson has converted his business into a cell-phone repair service and hired local high school students through a program that seeks to provide young adults with work experience. Mr. Jackson has also worked to build and renovate homes in a community that lacks quality affordable housing.

Full list in link

https://breaking911.com/biden-uses-sweeping-clemency-powers-for-the-first-time-full-list/

PUTIN VS THE DEEP STATE - PART THREE - THE WAR FOR THE WORLD - A Film By MrTruthBomb

https://www.bitchute.com/video/TEvURoLHZdmI/

United States v. SUSSMANN (1:21-cr-00582)

Memorandum in Opposition by FUSION GPS as to MICHAEL A. SUSSMANN re 64 MOTION to Compel Production of Documents for In Camera Review (Attachments: # 1 Declaration of Joshua A. Levy, # 2 Exhibit 1 to Levy Decl., # 3 Exhibit 2 to Levy Decl., # 4 Exhibit 3 to Levy Decl., # 5 Exhibit 4 to Levy Decl., # 6 Exhibit 5 to Levy Decl., # 7 Exhibit 6 to Levy Decl., # 8 Exhibit 7 to Levy Decl., # 9 Exhibit 8 to Levy Decl., # 10 Exhibit 9 to Levy Decl., # 11 Exhibit 10 to Levy Decl.)(Levy, Joshua) (Entered: 04/26/2022)

https://storage.courtlistener.com/recap/gov.uscourts.dcd.235638/gov.uscourts.dcd.235638.103.0.pdf

Pakistan’s Pivot to Russia and Ouster of Imran Khan

Connecting the dots of the 3-letter insurrection against the FLOTUS and the ouster of Imran Khan - false flag in DC?

Days before Imran Khan’s ouster on April 10 as prime minister in a no-trust motion in the parliament orchestrated by foreign powers, two impersonators were arrested in Washington for posing as US federal security officials and cultivating access to the Secret Service, which protects President Joe Biden, one of whom claimed ties to Pakistani intelligence.

Justice department assistant attorney Joshua Rothstein asked a judge not to release Arian Taherzadeh and Haider Ali, the men arrested on April 6 for posing as Department of Homeland Security investigators for two years before the arrest, the Guardian reported on April 8.

The men also stand accused of providing lucrative favors to members of the Secret Service, including one agent on the security detail of the first lady, Jill Biden. Prosecutors said in court filings they seized a cache of weapons from multiple DC apartments tied to the defendants.

Federal prosecutor Rothstein alleged one of the suspects, Haider Ali, “made claims to witnesses that he had connections to the ISI, Pakistan’s military intelligence service.”

The Department of Justice (DoJ) is treating the case as a criminal matter and not a national security issue. But the Secret Service suspended four agents over their involvement with the suspects.

“All personnel involved in this matter are on administrative leave and are restricted from accessing Secret Service facilities, equipment, and systems,” the Secret Service said in a statement.

Clearly, planning and preparations were underway to declare Pakistan a rogue actor sponsoring acts of subversion against the United States.

Soon after the US-led “regime change” in Pakistan and the formation of government by imperialist stooges, however, the tone of the judge and prosecutors changed.

The defendants were released on bail and placed in home detention, though they will not be allowed to go to airports or foreign embassies or to talk to any of the federal agents they allegedly duped.

During his hourlong ruling, Magistrate Judge Michael Harvey lambasted the Justice Department’s claims that the men were dangerous, were trying to compromise agents and were tied to a foreign government, the CNN reported on April 13.

Before his ouster as prime minister in a no-trust motion in the parliament on April 10, Imran Khan claimed that Pakistan’s Ambassador to US, Asad Majeed, was warned by Assistant Secretary of State Donald Lu that Khan’s continuation in office would have repercussions for bilateral ties between the two nations.

Shireen Mazari, a Pakistani politician who served as the Federal Minister for Human Rights under the Imran Khan government, quoted Donald Lu as saying: “If Prime Minister Imran Khan remained in office, then Pakistan will be isolated from the United States and we will take the issue head on; but if the vote of no-confidence succeeds, all will be forgiven.”

https://www.veteranstoday.com/2022/04/18/pakistans-pivot-to-russia-and-ouster-of-imran-khan/

US weapons, European supplicants block peace in Ukraine

“Captain” of Mexican Mafia in Laredo convicted

https://www.justice.gov/usao-sdtx/pr/captain-mexican-mafia-laredo-convicted

Four Members And Two Associates Of The Genovese Organized Crime Family Charged With Racketeering

https://www.justice.gov/usao-sdny/pr/four-members-and-two-associates-genovese-organized-crime-family-charged-racketeering

Fuck this baker

>>16159180 Food factory fires 2022 not just the US

>>16159242 Czech Foreign Minister Jan Lipavský joins the Atlantic Council for a discussion on the view from Prague on NATO, the war in Ukraine, and threat of authoritarianism to the West.

>>16159293 The Limits to Growth (Club of Rome)

>>16159303 Andrew Yang bought his followers

>>16159327 Supreme Court on Monday declined to block the new admissions policy for Virginia’s premier Thomas Jefferson High School over allegations its standards discriminate against Asian Americans

>>16159361 Pfizer asks FDA to authorize third COVID vax dose for children 5 to 11 years old

>>16159372 Biden Uses Sweeping Clemency Powers For The First Time | FULL LIST

>>16159399 New filing Opposition by FUSION GPS as to MICHAEL A. SUSSMANN re 64 MOTION to Compel Production of Document

>>16159472 “Captain” of Mexican Mafia in Laredo convicted

>>16159481 Four Members And Two Associates Of The Genovese Organized Crime Family Charged With Racketeering

Schumer Says the “Only Way” to Reduce Inflation Caused by Biden and Democrats is to Raise Taxes on Americans

Senate Majority Leader Chuck Schumer (D-NY) on Tuesday said the only way to reduce inflation caused by Joe Biden and the Democrats is to raise taxes on Americans.

Senators Schumer and Manchin discussed a new tax hike and deficit reduction bill as a way to combat inflation.

Bloomberg reported:

Key holdout Senator Joe Manchin said Tuesday he discussed a tax increase and deficit reduction bill with Senate Majority Leader Chuck Schumer as a way to reduce soaring inflation.

The West Virginia Democrat said he is open to using the fast-track budget process to bypass Republicans and ram corporate and individual tax increases through the Senate given that the GOP wants to “keep things the way they are” in the tax code. Manchin said that it would make sense to include cuts to prescription drug costs in the package, which would need the support of all 50 Senate Democrats.

“We talked about the tax code and doing something to combat inflation. He is just as concerned about inflation as I am,” Manchin said leaving Schumer’s office.

Some Democrats, however, remain skeptical that the party can reach a deal after the failed efforts late last year. Manchin, for instance, supports raising the corporate tax rate, but Arizona Senator Kyrsten Sinema, another Democratic holdout, has been adamant in her opposition to increasing it.

Speaking to reporters, Schumer said getting rid of Trump’s tax cuts is the only way to combat inflation.

“If you want to get rid of inflation, the only way to do it is to undo a lot of the Trump tax cuts and raise rates,” Schumer said. “No Republican is ever going to do that, so the only way to get rid of inflation is through reconciliation.”

https://www.thegatewaypundit.com/2022/04/schumer-says-way-reduce-inflation-caused-biden-democrats-raise-taxes-americans-video/

Pharmaceutical Companies in Ukraine in alphabetical order

AbbVie

We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives. We are AbbVie, a highly focused research-driven biopharmaceutical company.

Alpen Pharma Group

Alpen Pharma Group of Companies (Alpen Pharma Group) was found in 1997 and represents a union of companies, major business profile of which is to promote, distribute, produce and propagate medicinal products.

AstraZeneca

We are a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.

Biopharma

Biopharma is a leading developer and manufacturer of innovative blood-derived medicines (pharmaceutical products made of donated human blood), recombinant and spore-forming bacteria drugs.

Ever Pharma

Ever Pharma is a fully integrated specialty pharmaceuticals company focused on the research, development, production, and commercialization of products

Farmak a leader of the Ukrainian pharmaceutical market and the largest exporter of medicinal products since 2010.

GlaxoSmithKline

We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.

The company "InterChem" was founded in 1992 on the basis of the pilot plant of A.V. Bogatskiy Physico-Chemical Institute of the Academy of Sciences of Ukraine. Commercial activity started with the production of the unique products of fin…Read more about organization

InterChem's locations around the world

Lekhim

Today "Lekhim" Group of Companies - a powerful modern high-tech manufacturing company, one of the leading pharmaceutical companies of Ukraine on the development, manufacture and sale of high-quality and affordable medicines. Group of com…Read more about organization

Lekhim's locations around the world

Merck & Co.

We aspire to be the premier research-intensive biopharmaceutical company in the world For more than 125 years, Merck (known as MSD outside of the U.S. and Canada) has been inventing for life, bringing forward medicines and vaccines for many of the…Read more about organization

Merck & Co.'s locations around the world

Novartis

Our purpose is to reimagine medicine to improve and extend people’s lives. We use innovative science and technology to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to…Read more about organization

Novartis's locations around the world

Roche

We have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally. Roche was one of the first companies to br…Read more about organization

Roche's locations around the world

Sanofi

Sanofi is a global biopharmaceutical company focused on human health. Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical drugs principally in the prescription market, but the firm also develops over-the-c…Read more about organization

Sanofi's locations around the world

Sun Pharmaceutical Industries

Sun Pharmaceutical Industries Ltd. (Sun Pharma) is the fourth largest specialty generic pharmaceutical company in the world with global revenues of over US$ 4.5 billion. Supported by more than 40 manufacturing facilities, we provide high-quality,…Read more about organization

Sun Pharmaceutical Industries's locations around the world

Takeda

Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients…Read more about organization

Takeda's locations around the world

UCB

A global biopharma company, focusing on neurology and immunology. Our business is strong. Total revenue grew to €4.9 billion in 2019. We are more than 7,600 people in all four corners of the globe, inspired by patients and driven by science….Read more about organization

UCB's locations around the world

Unipharma

The Unipharma LLC was founded in 1992. Today it is a modern holding company, which works in different fields of pharmaceutical wholesale, retail and medical business.

https://ichgcp.net/pharma-list/country/ukraine

Is this cause of the smell of Rotting mass murderer?

Masks required at Madeleine Albright memorial service

The masks required notice comes the same day Vice President Kamala Harris tested positive for COVID

https://justthenews.com/government/white-house/masks-required-madeleine-albright-memorial-service

Leaked Audio - Twitter Company-Wide Meeting Addressing Elon Musk’s Takeover. MORE TO COME!